AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

Pantoprazole (As Sodium Sesquihydrate)

9 registrations across 1 African market— 9 active

Markets with Pantoprazole (As Sodium Sesquihydrate)

Recent registrations

Brand / ProductMarketHolderStatusExpires
PRAZTEK 20 mg🇿🇦South AfricaMacleods Pharmaceuticals SA (Pty) LtdactiveJan 1900
PRAZTEK 40 mg🇿🇦South AfricaMacleods Pharmaceuticals SA (Pty) LtdactiveJan 1900
KIMLOC 20 mg🇿🇦South AfricaMacleods Pharmaceuticals SA (Pty) LtdactiveJan 1900
KIMLOC 40 mg🇿🇦South AfricaMacleods Pharmaceuticals SA (Pty) LtdactiveJan 1900
AVIDEK 20 mg🇿🇦South AfricaMacleods Pharmaceuticals SA (Pty) LtdactiveJan 1900
AVIDEK 40 mg🇿🇦South AfricaMacleods Pharmaceuticals SA (Pty) LtdactiveJan 1900
NOLPAZA 40🇿🇦South AfricaLHC Pharmaceuticals (Pty) LtdactiveJan 1900
PRAZANT 20🇿🇦South AfricaActivo Health (Pty) LtdactiveJan 1900
NOLPAZA 20🇿🇦South AfricaLHC Pharmaceuticals (Pty) LtdactiveJan 1900

Pantoprazole (As Sodium Sesquihydrate) in Africa — Regulatory Overview

Pantoprazole (As Sodium Sesquihydrate) is registered across 1 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa. AfricaRegulatory refreshes this data daily from official government sources.

Of the 9 registrations, 9 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.